Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
oslif breezhaler
novartis europharm limited - indakaterol maleat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - oslif breezhaler je indicirano za zdravljenje bronchodilator vzdrževanje pretok zraka obstrukcijo pri odraslih bolnikih s kronično obstruktivno pljučno boleznijo.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
onbrez breezhaler
novartis europharm limited - indakaterol maleat - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - zdravilo onbrez breezhaler je indicirano za vzdrževanje bronhodilatatorja pri obtoku zračnega toka pri odraslih bolnikih s kronično obstruktivno pljučno boleznijo.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
tasigna
novartis europharm limited - nilotinib - levkemija, mielogena, kronična, bcr-abl pozitivna - antineoplastična sredstva - tasigna je primerna za zdravljenje:izobraževanje odraslih in pediatričnih bolnikih, ki so na novo zboleli za philadelphia kromosom pozitivno kronične myelogenous levkemijo (cml) v kronično fazo,pediatričnih bolnikih s philadelphia kromosom pozitivno cml v kronični fazi pa z odpornost ali nestrpnosti predhodno zdravljenje, vključno z imatinib. tasigna je primerna za zdravljenje:izobraževanje odraslih in pediatričnih bolnikih, ki so na novo zboleli za philadelphia kromosom pozitivno kronične myelogenous levkemijo (cml) v kronično fazo,odraslih bolnikih s kronično fazo in pospešeni fazi philadelphia kromosom pozitivno cml s odpornost ali nestrpnosti predhodno zdravljenje, vključno z imatinib. podatki o učinkovitosti pri bolnikih s cml v blastni krizi niso na voljo,pediatričnih bolnikih s kronično fazo philadelphia kromosom pozitivno cml s odpornost ali nestrpnosti predhodno zdravljenje, vključno z imatinib.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
pelmeg
mundipharma corporation (ireland) limited - pegfilgrastim - nevtropenija - immunostimulants, - zmanjšati trajanje neutropenia in pojavnost febrile neutropenia zaradi kemoterapijo.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
Slovenia -
Slovenia -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
closamectin
norbrook laboratories (ireland) limited -
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
cegfila (previously pegfilgrastim mundipharma)
mundipharma corporation (ireland) limited - pegfilgrastim - nevtropenija - immunostimulants, - skrajšanje trajanja nevtropenija in pojavnost vročinskih nevtropenija pri odraslih bolnikih, zdravljenih s citotoksično kemoterapijo za malignosti (razen kronično mieloično levkemijo in mielodisplastični sindrom).
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
aldara
viatris healthcare limited - imikvimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotiki in kemoterapevtiki za dermatološko uporabo - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
memantine mylan
mylan pharmaceuticals limited - memantinijev klorid - alzheimerjeva bolezen - other anti-dementia drugs, psychoanaleptics, - zdravljenje bolnikov z zmerno do hudo alzheimerjevo boleznijo.
Kesatuan Eropah -
Slovenia -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.